References
- Antonaccio M.J., Rubin B., Horovitz Z.P.: Effects of captopril in animal models of hypertension. Clin. Exp. Hyp. 2 (3&4): 613, 1980
- Barraclough M.A., Jones N.F., Marsden C.D., Bradford B.C.: Sodium and potassium intake, blood pressure and pressor actions of angiotensin in salt loaded and depleted rabbits. Experimentia 23: 553, 1967
- Bing J., Poulsen K.: Time course of changes in plasma renin after blockade of the renin system. Acta. Path. Microbiol. Scand. Sect. A, 83: 454, 1975
- Cowley A.W. Jr., McCaa R.E.: Acute and chronic dose response relationships of angiotensin, aldosterone and arterial pressure at varying levels of sodium intake. Circ. Res. 39: 788, 1976
- Davis J.O., Hartroft P.M., Titus E.O., Carpenter C.C.J, Ayers C.R., Spiegel H.E.: Role of the renin-angiotensin system in the control of aldosterone secretion. J. Clin. Invest. 41: 378, 1962
- Gavras H., Waeber B., Gavras I., Biollaz J., Brunner H.R., Davies R.O.: Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421". Lancet 12;2 (8246): 543, 1981
- Haber E.T., Koerner T., Page L.B., Kliman B., Purnode A.: Application of radioimmunoassay of angiotensin I to the physiologic measurements of plasma renin activity in normal subjects. J. Clin. Endocrinol. 29: 1349, 1969
- Hall J.E. Guyton A.C., Smith M.J. Jr., Coleman T.G.: Chronic blockade of AII formation during Na-deprivation. Am. J. Physiol. 237 (6): F424, 1979
- Hall J.E., Coleman T.G., Guyton A.C., Balfe J.W., Salgado H.C.: Intrarenal role of AII and (des-asp1) angiotensin II. Am. J. Physiol. 236: F252, 1979
- Hall J.E.,Guyton A.C., Smith M.J.Jr., Coleman T.G.:Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am. J. Physiol. 239: F271, 1980
- Hollenberg N.K., Cheritz W.R., Adams D.F., Williams G.: Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J. Clin. Invest. 54: 34, 1974
- Hollenberg N.K., Williams G.H., Burger B., Ishikawa I., Adams D.F.: Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-sar, 8-ala angiotensin II in normal man. J. Clin. Invest. 57: 39, 1976
- Hollenberg N.K., Williams G.M.: Angiotensin as a renal, adrenal and cardiovascular hormone: Responses to saralasin in normal man and in essential and secondary hypertension. Kid. Int. 15: s 29, 1979
- Kaplan N.M., Silah J.G.: Effect of angiotensin II on the blood pressure in humans with hypertensive disease. J. Clin. Invest. 43: 659, 1965
- Laragh J.H.: Interrelationships between angiotensin, norepinephrine, epinephrine, aldosterone secretion and electrolyte metabolism in man. Circulation 25: 203, 1962
- MacGregor G., Markandu N., Bayless J., Roulston J.E., Sqires M., Morton J.J.: Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK-421): Evidence for role of renin system in normotensive subjects. BMJ 283: 401, 1981
- Millar J.A., Johnston C.I.: Sequential changes in circulating levels of angiotensin I and II, renin and bradykinin after captopril. Med. J. Aust. Sped. Supp. 2: XV, 1979
- Morrison D.F.: Multivariate statistical methods. McGraw-Hill Book Co., 1967
- Nasjletti A., Colina-Chourio J., McGiff J.C.: Disappearance of bradykinin in the renal circulation of dogs, effects of kininase inhibition. Circ. Res. 37: 59, 1975
- Reid W.D., Laragh J.H.: Sodium and potassium intake, blood pressure and pressor response to angiotensin. Proc. Soc. Exp. Biol. Med. 120: 26, 1965
- Thurston H., Laragh J.H.: Prior receptor occupancy as a determinant of the pressor activity of infused angiotensin II in the rat. Circ. Res. 36: 113, 1975.